(secondQuint)Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Cancer.

 1.

 Investigate the tolerance of Chlorogenic acid for injection in human body, determine the Maximum Tolerated Dose (MTD) and Dose-Limiting Toxicity (DLT) of Chlorogenic acid for injection in the advanced malignant tumor subjects; 2.

 Determine the human pharmacokinetics characteristic of Chlorogenic acid for injection; 3.

 Preliminary observation the effectiveness and effective dose; 4.

 Provide the basis for the dosage regimen of phase II/III.

.

 Tolerance and Pharmacokinetic Study of Chlorogenic Acid to Advanced Cancer@highlight

The purpose of this study: Determining the Maximum Tolerated Dose (MTD), Dose-Limiting Toxicity (DLT), pharmacokinetics characteristic, and dosage regimen of phase II/III of Chlorogenic acid for injection in the advanced malignant tumor subjects;